Recovery of Visual Field Defects: a Large Clinical Observational Study Using Vision Restoration Therapy
Overview
Authors
Affiliations
Purpose: In small experimental trials, vision restoration therapy (VRT), a home-based rehabilitation method, has shown to enlarge the visual field and improve reaction times in patients with lesion involving the CNS. We now evaluated the outcome of VRT in a large sample of clinical patients and studied factors contributing to subjective and objective measures of visual field alterations.
Methods: Clinical observational analysis of visual fields of 302 patients before and after being treated with computer-based vision restoration therapy for a period of 6 months at eight clinical centers in central Europe. The visual field defects were due to ischemia, hemorrhage, head trauma, tumor removal or anterior ischemic optic neuropathy. Primary outcome measure was a visual field assessment with super-threshold perimetry. Additionally, conventional near-threshold perimetry, eye movements and subjective reports of daily life activities were assessed in a subset of the patients.
Results: VRT improved patients' ability to detect super-threshold stimuli in the previously deficient area of the visual field by 17.2% and these detection gains were not significantly correlated with eye movements. Notable improvements were seen in 70.9% of the patients. Efficacy was independent of lesion age and etiology, but patients with larger areas of residual vision at baseline and patients>65 years old benefited most. Conventional perimetry validated visual field enlargements and patient testimonials confirmed the improvement in every day visual functions.
Conclusions: VRT improves visual functions in a large clinical sample of patients with visual field defects involving the CNS, confirming former experimental studies.
Werth R Diagnostics (Basel). 2024; 14(17).
PMID: 39272749 PMC: 11393927. DOI: 10.3390/diagnostics14171965.
Namgung E, Kim H, Kim Y, Kim Y, Lee E, Lee J J Clin Neurol. 2024; 20(5):509-518.
PMID: 39227334 PMC: 11372206. DOI: 10.3988/jcn.2024.0015.
Hong H, Jeong M, Kim K Ann Rehabil Med. 2024; 48(2):146-154.
PMID: 38658046 PMC: 11058365. DOI: 10.5535/arm.230028.
The effects of occipital and parietal tDCS on chronic visual field defects after brain injury.
Diana L, Casati C, Melzi L, Bianchi Marzoli S, Bolognini N Front Neurol. 2024; 15:1340365.
PMID: 38419713 PMC: 10899507. DOI: 10.3389/fneur.2024.1340365.
Leitner M, Ladek A, Hutzler F, Reitsamer H, Hawelka S Front Neurol. 2023; 14:1114718.
PMID: 37456634 PMC: 10339290. DOI: 10.3389/fneur.2023.1114718.